Siegfried Holding Equity 2025

Siegfried Holding Aktienanalyse

What does Siegfried Holding do?

The Siegfried Holding AG is a Swiss pharmaceutical company based in Zofingen, which operates worldwide. The company's history dates back to 1873, when the pharmacist and chemist Franz von Siegfried founded the "First Aid Pharmacy". Over the years, the company has developed into an important producer of pharmaceutical ingredients. The business model of Siegfried Holding AG is based on the production and distribution of pharmaceutical ingredients, intermediate products, and finished products. The products are used in various areas, such as veterinary medicine, human medicine, or the chemical industry. Siegfried operates various divisions that focus on different segments of the value chain. These divisions include production, contract development and manufacturing (CDMO), and commercial products. In the production division, the company produces pharmaceutical ingredients and intermediate products. The CDMO business offers custom development and manufacturing services for the pharmaceutical and biotech industry. In the commercial products division, finished products such as cough medicine, antidepressants, or blood pressure reducers are distributed. Among the products offered by Siegfried are the active ingredient carbamazepine, which is used as an anticonvulsant and for the treatment of bipolar disorder. Another active ingredient is acetaminophen, which is used as a painkiller and fever reducer. Siegfried also produces the active ingredient sotalol, which is used to treat heart rhythm disorders. In the context of the CDMO business, Siegfried also develops and produces custom products for the pharmaceutical and biotech industry. This includes the manufacturing of clinical trial preparations, the implementation of process developments, and scale-up productions of active ingredients and finished products. In recent years, Siegfried Holding AG has made several acquisitions to expand its business and strengthen its market presence. In 2016, the company acquired Bexbach-based Saltigo GmbH, a specialist in the production of customer-specific fine chemicals. Two years later, Siegfried acquired the active ingredient production business of Alcami, a US pharmaceutical company. In summary, it can be said that Siegfried Holding AG is an established Swiss pharmaceutical company specializing in the production and distribution of pharmaceutical ingredients, intermediate products, and finished products. In recent years, the company has made several acquisitions to expand its market presence and diversify its business. Siegfried Holding ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Siegfried Holding's Equity

Siegfried Holding's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Siegfried Holding's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Siegfried Holding's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Siegfried Holding's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Siegfried Holding’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Siegfried Holding stock

What is the equity of Siegfried Holding this year?

Siegfried Holding has equity of 838.24 M CHF this year.

What was the equity of Siegfried Holding compared to the previous year?

The equity of Siegfried Holding has increased/decreased by 5.98% increased compared to the previous year.

What impact does a high equity have on investors of Siegfried Holding?

A high equity is advantageous for investors of Siegfried Holding as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Siegfried Holding?

A low equity can be a risk for investors of Siegfried Holding, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Siegfried Holding affect the company?

An increase in equity of Siegfried Holding can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Siegfried Holding affect the company?

A reduction in equity of Siegfried Holding can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Siegfried Holding?

Some factors that can affect the equity of Siegfried Holding include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Siegfried Holding so important for investors?

The equity of Siegfried Holding is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Siegfried Holding take to change the equity?

To change equity, Siegfried Holding can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Siegfried Holding pay?

Over the past 12 months, Siegfried Holding paid a dividend of 3.4 CHF . This corresponds to a dividend yield of about 0.34 %. For the coming 12 months, Siegfried Holding is expected to pay a dividend of 3.98 CHF.

What is the dividend yield of Siegfried Holding?

The current dividend yield of Siegfried Holding is 0.34 %.

When does Siegfried Holding pay dividends?

Siegfried Holding pays a quarterly dividend. This is distributed in the months of August, July, June, June.

How secure is the dividend of Siegfried Holding?

Siegfried Holding paid dividends every year for the past 19 years.

What is the dividend of Siegfried Holding?

For the upcoming 12 months, dividends amounting to 3.98 CHF are expected. This corresponds to a dividend yield of 0.39 %.

In which sector is Siegfried Holding located?

Siegfried Holding is assigned to the 'Health' sector.

Wann musste ich die Aktien von Siegfried Holding kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Siegfried Holding from 5/7/2024 amounting to 3.6 CHF, you needed to have the stock in your portfolio before the ex-date on 5/3/2024.

When did Siegfried Holding pay the last dividend?

The last dividend was paid out on 5/7/2024.

What was the dividend of Siegfried Holding in the year 2024?

In the year 2024, Siegfried Holding distributed 3.4 CHF as dividends.

In which currency does Siegfried Holding pay out the dividend?

The dividends of Siegfried Holding are distributed in CHF.